Use of Conservative Therapies Before Hysterectomy for Uterine Leiomyomas.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 36649332.
- Also identified by DOI 10.1097/AOG.0000000000005053.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We used a claims database to identify patients with uterine leiomyomas who underwent hysterectomy between 2011 and 2019. Use of conservative medical and surgical interventions in the 24-month period before hysterectomy was explored. Overall, 59.7% of patients did not receive any conservative intervention before hysterectomy. Individuals who underwent hysterectomy in more recent years and those with endometriosis, abnormal bleeding, greater comorbidity, or prior venous thromboembolism were more likely to receive conservative interventions.
Medical subject headings
- Uterine Neoplasms
- Leiomyoma
- Endometriosis